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Abstract
Objective—To better understand the high variability in response seen when treating human
subjects with restorative therapies post-stroke. Preclinical studies suggest that neural function,
neural injury, and clinical status each influence treatment gains, therefore the current study
hypothesized that a multivariate approach incorporating these three measures would have the
greatest predictive value.
Methods—Patients 3-6 months post-stroke underwent a battery of assessments before receiving
3-weeks of standardized upper extremity robotic therapy. Candidate predictors included measures
of brain injury (including to gray and white matter), neural function (cortical function and cortical
connectivity), and clinical status (demographics/medical history, cognitive/mood, and
impairment).
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Results—Among all 29 patients, predictors of treatment gains identified measures of brain injury
(smaller corticospinal tract (CST) injury), cortical function (greater ipsilesional motor cortex (M1)
activation), and cortical connectivity (greater inter-hemispheric M1-M1 connectivity).
Multivariate modeling found that best prediction was achieved using both CST injury and M1-M1
connectivity (r2=0.44, p=0.002), a result confirmed using Lasso regression. A threshold was
defined whereby no subject with >63% CST injury achieved clinically significant gains. Results
differed according to stroke subtype: gains in patients with lacunar stroke were exclusively
predicted by a measure of intra-hemispheric connectivity.
Interpretation—Response to a restorative therapy after stroke is best predicted by a model that
includes measures of both neural injury and function. Neuroimaging measures were the best
predictors and may have an ascendant role in clinical decision-making for post-stroke
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rehabilitation, which remains largely reliant on behavioral assessments. Results differed across
stroke subtypes, suggesting utility of lesion-specific strategies.

NIH-PA Author Manuscript
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Introduction
Stroke is a very heterogeneous disease, with substantial variability between patients in
response to treatment. This extends to clinical trials, where higher inter-subject variance
means reduced study power and increased cost1. This issue has undergone considerable
discussion in relation to acute stroke trials, where CT and MRI measures are under study to
improve prediction of individual patient responses to reperfusion therapy2, 3. A similar
challenge exists in the setting of restorative therapies, as the best approach to predicting
treatment response remains undetermined4.
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Efforts to identify predictors of response to a restorative treatment in humans are informed
by preclinical studies5. Behavioral gains in animals given a restorative therapy after
experimental stroke has been linked to growth-related events in the brain that include axonal
outgrowth, increased dendritic branching, and release of growth factors6-8. Predictors of
these behavioral gains fall into three categories of measurement: (1) neural injury such as
infarct topography9, 10 and infarct volume9-11; (2) neural function such as motor cortex
integrity12, 13; and (3) clinical status, such as baseline behavioral assessments13, age8, 14, 15
and vascular risk factors8.
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Results of human studies have been largely concordant, with predictors of response to a
restorative therapy post-stroke generally grouped as measures of: (1) neural injury such as
extent of injury to white matter or gray matter16-20; (2) neural function such as functional
activation21-24, functional connectivity25, 26, and neurophysiological status19, 22; and (3)
clinical measures such as demographics27 and baseline behavioral status16, 23, 28, 29. Some
data in humans suggest that genetic variation, particularly in the genes for brain-derived
neurotrophic factor (BDNF) and apolipoprotein E (ApoE), might also be related to variance
in response to a restorative therapy, as polymorphisms for each have been associated with
poorer post-stroke outcome and reductions in some forms of cortical plasticity30-32. In
addition, stroke subtype is important to many aspects of clinical decision-making for
patients with cerebrovascular disease33, 34 and has been suggested as important to recovery
potential and improvements with restorative therapies in the chronic phase of stroke,35 but
this issue has received limited attention.
The number and diversity of these predictive measures reflects the complexity of neural
repair after stroke. Optimal prediction of response to a restorative therapy may therefore
likely require a multivariate approach that incorporates several types of measure36, 37.
However, only a few human studies have taken this approach16, 20, 22, 23, 38, and none has
taken a multivariate approach that included measures of neural injury, functional activation,
functional connectivity, genetics, and clinical/demographic measures in a heterogeneous
stroke population.
Ann Neurol. Author manuscript; available in PMC 2016 January 01.
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The current study addressed these issues, with the primary hypothesis being that pre-therapy
measures of neural injury, neural function, and clinical status together would best predict
response to a restorative therapy, and would surpass the performance of any single measure.
An additional hypothesis was that the best predictors of treatment gains differ according to
stroke subtype, focusing on lacunar vs. non-lacunar stroke given substantial differences in
their pathophysiology and outcomes39-45.

Materials and methods
Patient enrollment
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Forty-one patients with chronic stroke gave informed consent to be part of a longitudinal
study of standardized robotic-assisted hand therapy (clinicaltrials.gov ID# NCT01244243)
that was approved by the UC Irvine Institutional Review Board. Inclusion and exclusion
criteria (Table 1) aimed to capture a population at a specific time point in stroke recovery
(close to the time when spontaneous motor recovery is complete 46, 47), with confirmed
plateau in arm motor recovery, and within a wide but prescribed range of motor deficits. In
one patient, baseline MRI revealed an incidental finding that met exclusion criteria,
rendering the patient ineligible for the study. The forty eligible patients were studied as
below.
Baseline assessments (Table 2) of candidate predictors were obtained, after which patients
underwent a course of robotic therapy; all patients received robotic therapy, there was no
comparison or placebo arm. These baseline assessments were organized into seven
categories: 1) demographics/medical history; 2) cognitive/mood; 3) genetics; 4) impairment;
5) brain injury; 6) cortical function; and 7) cortical connectivity.
Robotic therapy
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Patients underwent twelve treatment sessions of robotic hand therapy over three weeks: 2
hours/day, 4 days/week for a total of 24 hours. All patients completed at least eleven of
twelve robotic therapy sessions. Therapy consisted of repeated grasp-release (‘close’ and
‘open’) movements of the affected hand, with grasp coupled to wrist extension and release
to wrist flexion, using a pneumatically-actuated robotic device described previously48. The
average number of movement repetitions at each of the 12 sessions, recorded by the robot,
was 954 for the fingers, 2,579 for the thumb, and 1,298 for the wrist; the thumb is greatest
because some games required movement of four fingers and thumb only while other games
required movement of wrist and thumb only.
Demographics/history
Medical history was obtained and acute stroke hospitalization records reviewed.
Cognitive/mood
included the Mini Mental State Exam and Geriatric Depression Scale.

Ann Neurol. Author manuscript; available in PMC 2016 January 01.
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Impairment
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A single rater performed all behavioral assessments. Patients were assessed before, and onemonth, after a three-week course of standardized robotic hand therapy. Baseline Fugl-Meyer
(FM) and Action Research Arm Test (ARAT) assessments were performed twice before
beginning therapy (once at baseline screening and again 1-3 weeks later) to ensure stability
of motor status (e.g., the second FM score was required to be within 3 points of the first
score), and averaged for each patient.
Genetics
A blood sample was obtained, and BDNF val66met polymorphism plus ApoE4 allele status
were determined as described previously 31.
Brain injury
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Image acquisition—Magnetic resonance imaging was performed at the second baseline
visit and acquired using a 3.0T Philips Achieva system. Anatomical imaging consisted of a
high-resolution T1-weighted image, T2-FLAIR, and diffusion tensor imaging (DTI). Highresolution T1-weighted images were acquired using a 3D MPRAGE sequence (repetition
time (TR)=8.5 ms, echo time (TE)=3.9 ms, slices=150, voxel size=1 × 1 × 1 mm3). T2FLAIR (TR=11000 ms, TE=125 ms, slices=31 slices, voxel size=.58 × .58 × 5 mm3) and
intracranial MR angiogram (TR=23 ms, TE=3.45 ms, slices=100, voxels size=.31 × .31 × .7
mm3) images were also acquired. One set of diffusion-weighted images was acquired (32
directions; b-value 1000 smm-2; 60 slices; voxel size=1.75 × 1.75 × 2 mm3).
Image analysis—Image analysis was performed blinded to clinical data. Three classes of
brain injury metrics were extracted: (1) total brain injury (infarct volume); (2) gray matter
injury (to primary motor cortex (M1), dorsal premotor cortex (PMd), plus total cortical
injury); and (3) white matter injury (percent lesion overlap with corticospinal tract (CST), or
CST integrity within ipsilesional cerebral peduncle using DTI fractional anisotropy (FA)
values).

NIH-PA Author Manuscript

Infarct volume—Using MRIcron (http://www.mccauslandcenter.sc.edu/mricro/mricron),
each patient's infarct was outlined by hand on the T1-weighted MRI image, informed by the
T2-FLAIR image as described previously38.
Gray matter injury—To determine how injury to specific regions of gray matter is related
to treatment-induced behavioral gains, the degree of overlap between cortical regions of
interest (ROI) and each infarct was calculated. Using FSL, the whole-brain cortical ROI was
generated via FAST segmentation of the 1mm3 T1 template. Precentral gyrus (M1) and PMd
gray matter ROIs were manually drawn on this template. These ROI masks and the stroke
masks were then multiplied to generate an overlap image in MNI space. The number of
infarct voxels overlapping with each of the three ROIs was counted and expressed as cc.
Injury was recorded as both a continuous and a dichotomous variable.

Ann Neurol. Author manuscript; available in PMC 2016 January 01.
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White matter injury—White matter integrity within the CST was quantified using FSL to
probe FA within the CST at the level of the cerebral peduncle (CP) as described
previously38.
Corticospinal tract injury was also evaluated as the amount of overlap in MNI stereotaxic
space between the normal corticospinal tract descending from M118, 49, generated as
described previously38, and each patient's infarct. This method has been shown to perform
comparably to calculating lesion overlap using tracts generated from patients' brains50.
Cortical function

NIH-PA Author Manuscript

Image Acquisition—Three runs of blood oxygenation level-dependent fMRI images were
acquired using a T2*-weighted gradient-echo echo planar imaging sequence, as described
previously38. Subjects were visually guided to use the paretic distal upper extremity to
execute the grasp-release movements that were at the center of robotic training, while
wearing a splint that was a non-actuated plastic exoskeleton identical to the robotic
interface. Prior to MRI data acquisition, patients were trained until each could independently
perform this task. Throughout the fMRI scan, investigators visually monitored patient
movements.
Image Analysis—Two measures of brain function were extracted from fMRI images: (1)
activation beta (contrast) estimate and (2) activation volume, each measured in four ROIs,
right and left M1 plus right and left PMd. Functional data were processed as described
previously38.
Cortical connectivity
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Functional connectivity was assessed as the temporal correlation using an ROI-ROI
approach. After the fMRI data were preprocessed in SPM8, intra- and inter-hemispheric
functional connectivity metrics were calculated using the Conn toolbox51. Time courses
were filtered between 0.008 and 0.13 to minimize low-frequency drift and high-frequency
noise. Within-subject realignment parameters, outliers, and main session effects were
included as first-level covariates. The three connections evaluated for functional
connectivity were ipsilesional M1-ipsilesional PMd (iM1-iPMd), ipsilesional M1contralesional M1 (iM1-cM1), and ipsilesional M1-contralesional PMd (iM1-cPMd). Fishertransformed correlation coefficients were extracted for each connection in each patient.
Patient characteristics
Data from twenty-nine patients were available for analysis (Table 2). Of the forty patients
enrolled, four could not complete MRI due to claustrophobia and seven patients were
excluded due to excessive head motion during fMRI scanning. These twenty-nine patients
did not differ significantly from the excluded eleven patients in age or baseline FM (p>0.1).
The stroke was ischemic in 27 and hemorrhagic in two.
Demographics/medical history—Mean time post-stroke was 4.3 months and mean age
was 56.5 years. All but two were right-handed.
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Cognitive/mood—Overall, patients were neither cognitively impaired nor clinically
depressed.
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Genetics—The genotypic frequencies for the BDNF val66met polymorphism and the
ApoE4 allele were in Hardy-Weinberg equilibrium, and these polymorphisms were present
in 28% and 14% of patients, respectively.
Impairment—Overall, patients had mild global impairment and moderate-severe upper
extremity motor impairment. Preserved voluntary movement (≥5 degrees of active range of
motion) was present in the affected index finger metacarpophalangeal joint in 28/29, and in
affected wrist in 25/29 patients.

NIH-PA Author Manuscript

Brain injury—Infarct volumes were moderate overall (average=33cc, range=0.6cc-178cc).
The stroke affected left hemisphere in 55% of patients; dominant hemisphere, in 48%.
Approximately one-third of patients had injury to PMd cortex and half had injury to M1
cortex; among these patients, extent of infarct overlap was greater with M1 than PMd.
Extent of CST injury determined by lesion overlap showed substantial variability across
patients (55±33%, range 0-100%). Similar results were obtained when determining extent of
CST injury using DTI, with mean FA in the affected cerebral peduncle being 0.38±0.12,
significantly (p<0.0001) lower than unaffected cerebral peduncle values (0.55±0.1),
indicating reduced integrity within the ipsilesional CST.
Cortical function—Patients varied in the quality of performance of the requested
unilateral paretic hand grasp/release movement during the active blocks of fMRI scan
acquisition, with full range of motion present in 38%, partial movement in 51%, and no
visible movement (due to weakness) in 11%. In addition, 24% of patients had at least one
associated movement52 in the non-affected hand, the presence of which was associated with
greater contralesional M1 activation (contrast estimate, p=0.009; activation volume, p=0.03)
but not with differences in any other fMRI activation/connectivity measure, nor with a
difference in treatment gains (p=0.99).
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This task was associated with prominent bilateral activation within M1 and PMd. Activation
contrast estimates within ipsilesional M1 were larger than within contralesional M1
(p=0.0002). Activation volumes were larger within ipsilesional M1 as compared to
contralesional M1 (p=0.005), ipsilesional PMd (p=0.002), and contralesional PMd (p=0.03).
Magnetic resonance angiogram, available in twenty-three patients, disclosed significant
ipsilesional internal carotid artery or middle cerebral artery disease in 26% of patients; none
of the fMRI activation parameters differed significantly according to presence vs. absence of
these cerebrovascular observations.
Cortical connectivity—During unilateral grasp/release of the paretic hand, functional
connectivity was present in all three ipsilesional M1 connections (iM1-iPMd, iM1-cM1,
iM1-cPMd). Functional connectivity was significantly greater in iM1-iPMd as compared to
iM1-cM1 (p=0.04) and iM1-cPMd (p=0.003). There was no significant difference between
iM1-cM1 and iM1-cPMd connectivity (p=0.60). Note that correlation coefficients were not
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significantly related to any measure of cortical function, with the sole exception being iM1cPMd functional connectivity and ipsilesional M1 activation volume (p=0.005), and
correlation coefficients were not significantly different in relation to stroke subtype.
Statistical analyses
Predictors of treatment-induced behavioral gains - bivariate screening—
Bivariate screening was performed to identify the strongest predictors of treatment-induced
behavioral gains. The primary outcome measure was change in arm motor status from
baseline to one month post-therapy, defined by combining change measures in impairment
(change in upper extremity FM) and in functional activity (change in ARAT) via principal
component analysis (PCA)53; only the first component was used to define treatment-induced
motor gains, as this accounted for 84% of variance in these two behavioral outcomes.
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Bivariate screening determined the significance of the relationship between each baseline
measure and the dependent measure (treatment-induced motor gains). Parametric statistical
methods were used for measures for which the normality assumption was valid, using raw or
transformed values; otherwise non-parametric methods were used. Continuous variables
were evaluated using Pearson's correlation coefficient or Spearman's rank order, while
categorical variables were evaluated using Student's t-test or the Wilcoxon signed-rank test.
All analyses were two-tailed with alpha=0.05 and used JMP-8 software (SAS Institute, Inc.,
Cary, NC). For each of the seven categories, results of this bivariate screening determined
whether any baseline measure survived as a predictor of treatment gains and would be
advanced to multivariate modeling.
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Predictors of treatment-induced behavioral gains - multivariate modeling—The
primary predictive model used a forward stepwise multivariate linear regression approach
(0.1 to enter, 0.15 to leave the model), advancing the most significant predictors identified in
bivariate screening. The strongest bivariate predictor within each of the seven categories was
advanced as long as bivariate screening showed p<0.1. If a category had more than one
variable with p<0.1 during bivariate screening, only the variable with the strongest
correlation coefficient was advanced into the stepwise forward model. In order to understand
whether results vary according to stroke subtype, the above analyses were repeated
separately for the 8 patients with a lacunar infarct (defined as an infarct that is subcortical
and has infarct volume <4cc54) and for the 21 patients with a non-lacunar infarct.
Predictors of treatment-induced behavioral gains - group Lasso regression
method—To confirm findings from multivariate modeling, a secondary approach to
predictive modeling used a penalized regression approach. Numerous variables have been
reported to influence stroke outcomes55-59. The statistical question is therefore highdimensional, suggesting the utility of a secondary approach that used a penalized regression,
or regularization,60 method for predictive modeling, which (a) makes conclusions based on
joint consideration of all variables simultaneously, and (b) reduces overfitting, which can be
associated with models that perform well on one dataset but do not generalize well to new
datasets). Lasso (least absolute shrinkage and selection operator61) was chosen as the
penalized regression model because it selects a subset of useful predictors from a total pool
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of candidate predictors and, unlike linear regression, minimizes the influence of outliers.
Specifically, a group Lasso model was used, which is similar to the standard Lasso
regression but takes the grouping of variables (i.e., categories) into account62. The Lasso
procedure requires a tuning parameter, lambda, which was chosen in a standard way through
(five-fold) cross-validation. Numerical variables were standardized before running the Lasso
model.

Results
Treatment-induced behavioral gains
Patients showed significant gains across the 3 weeks of robotic therapy, with improvements
from baseline to 1 month post-therapy in both primary endpoints (FM: 3.7 points, p<0.0001;
ARAT: 4.1 points, p=0.002).
Prediction of treatment-induced behavioral gains -- all patients

NIH-PA Author Manuscript

Bivariate screening—When each of the variables from the seven categories was
examined in bivariate screening, four categories (demographics, impairment, genetics, and
cognitive/mood) had no variables significantly predicting gains, while three categories
(brain injury, cortical function, and cortical connectivity; Table 3) had at least one variable
that significantly predicted treatment-induced behavioral gains. The most significant
bivariate predictor of gains from each of these three, respectively, was percent CST injury
determined by lesion overlap (Figure 1A: r=-0.49, p=0.007), ipsilesional M1 activation
contrast estimate (r=0.37, p=0.045), and iM1-cM1 functional connectivity (Figure 1B:
r=0.45, p=0.01). Excluding the two subjects with hemorrhagic stroke had no effect on
results. Excluding patients with ≥50% damage to cortical ROIs63 had no effect on
connectivity findings.
For one of these three measures (brain injury: percent CST injury), a threshold was
identified for achieving the minimal clinically important difference (MCID) for treatmentinduced motor gains in the setting of chronic stroke (4.25 points on the FM scale64): 63%
injury to the CST. None of the 12 patients with ≥63% CST injury achieved the MCID. Note
that most (65%) subjects with <63% CST injury did achieve the MCID, and that no MCID
threshold was found for cortical function or cortical connectivity.
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Multivariate modeling—To generate a predictive model, the three variables that best
correlated with change in behavior based on bivariate screening were entered into
multivariate analyses. The resultant model predicted 44% of variance in treatment-induced
behavioral gains (p=0.002; Table 4); a measure of brain injury (percent CST injury) and a
measure of cortical connectivity (iM1-cM1 functional connectivity) remained significant in
this model.
Lasso regression method—To independently verify the results from bivariate
screening, Lasso regression was applied to the same 29 patients' data. This analysis
identified the same two categories--brain injury and cortical connectivity--as having
variables significantly predictive of treatment-induced behavioral gains. In the brain injury
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category, the selected variables were percent injury to the CST and cortical injury (yes/no).
In the cortical connectivity category, the selected variable was the iM1-cM1 functional
connectivity correlation coefficient. Estimated Lasso coefficients appear in Figure 2.
Prediction of treatment-induced behavioral gains -- stroke subtype
In order to understand how differences in stroke pathophysiology influence prediction of
treatment-induced behavioral gains, the above analyses were repeated examining only the
subgroup of patients with a lacunar infarct (n=8). Baseline measures in this subgroup were
overall similar to those found in the subgroup of 21 patients with a non-lacunar infarct
(Table 2), except that patients with lacunar infarct had higher prevalence of
hypercholesterolemia (p=0.03), less severe sensory deficits (p=0.001), and less severe injury
by several measures such as percent CST injury by lesion overlap (p=0.04). Patients with a
lacunar infarct had a greater treatment response compared to patients with a non-lacunar
infarct (5.8±3.2 vs. 2.8±3.4 for FM, p=0.02; 8.8±7.0 vs. 2.3±5.1 for ARAT, p=0.02).
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Bivariate screening in patients with a lacunar infarct found significant predictors of
treatment-induced behavioral gains in only two categories: cortical function (ipsilesional M1
activation contrast estimate (r=0.79, p=0.02, Figure 3A) and ipsilesional M1 activation
volume (r=0.76, p=0.03)) and cortical connectivity (iM1-iPMd correlation coefficient
(r=0.81, p=0.02, Figure 3B)). Because of significant collinearity between the ipsilesional M1
contrast estimate and the iM1-iPMd correlation coefficient, a multivariate model was not
pursued for the lacunar subgroup. These findings contrast with results of bivariate screening
in the subgroup of 21 patients with a non-lacunar infarct, among whom the significant
predictors of motor gains were the same as in the full cohort of 29 subjects: percent CST
injury (r=-0.51, p=0.02) and iM1-cM1 functional connectivity (r=0.56, p=0.009).

Discussion
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Stroke is a very heterogeneous disease, with patients showing wide differences in measures
of injury, neural function, and response to therapy. These sources of variability complicate
prescription of restorative therapies, as the best predictor(s) of response to a post-stroke
restorative therapy remains uncertain. Concordant with preclinical studies, the results of the
current study suggest that neural injury and neural function remain important in human
subjects: multivariate modeling found that a measure of brain injury (smaller extent of CST
injury) combined with a measure of cortical connectivity (greater iM1-cM1 functional
connectivity) best predicted greater treatment-induced behavioral gains, a result
independently confirmed by the group Lasso regression model. These variables
outperformed traditional predictors of stroke outcome such as age or infarct volume.
Different results emerged when examining only patients with a lacunar infarct. Overall,
these findings emphasize the importance of a multivariate approach to patient selection and
stratification for restorative therapies after stroke.
Prediction of treatment-induced behavioral gains -- all patients
The current study found that a combination of brain injury and cortical connectivity
measures was best for predicting treatment gains. These findings broadly agree with a prior
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study that also found combining measures of neural injury (CST FA) and neural function
(motor evoked potential) to be optimal for predicting upper extremity treatment gains in
patients with chronic stroke16, and agree with preclinical studies that emphasize neural
injury and neural function as key determinants of training-induced behavioral gains after
stroke13, 15. This combined approach explained far more variance in outcome (44%, Table
4) than that provided by any single measure (up to 24%, Table 3). Clinical measures were
also hypothesized to be significant predictors, but none reached significance (Tables 3,
Figure 2). That neuroimaging measures were the best predictors takes on increased
significance in light of the fact that triage and distribution of post-stroke rehabilitative care
is still primarily based on behavioral assessments65.
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Among the measures of neural injury, extent of CST injury measured with the lesion overlap
method best predicted treatment-induced motor gains, consistent with prior studies using the
current method18, 19 or using related methods49, 66 for estimating CST injury. The current
study also confirmed a prior report18 that whenever a therapy targets a specific neural
system (e.g., the motor system), an injury measure focused on that specific neural system
(CST injury) is more precise than a global injury measure (e.g., infarct volume) for
predicting treatment gains (Table 3). The presence of cortical injury was also an important
predictor of treatment gains (Table 3) and furthermore was identified as significant by the
Lasso regression method. This is consistent with previous studies that found significant
differences in treatment response67 and neurophysiological integrity19 according to whether
or not the stroke involved the cerebral cortex. Together, the results highlight the importance
of measuring both white and gray matter injury, and of considering system-specific injury
measures.
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A novel finding was an injury threshold for achieving the minimal clinically important
difference (MCID) in arm gains from robotic therapy. In 0 of the 12 patients with >63%
injury did treatment gains reach the MCID (>4.25 points on the arm motor FM scale)64. This
suggests that a certain amount of the CST must be intact for a patient to derive clinically
significant benefit from upper extremity therapy, similar to what has been proposed for
walking after CST injury68 or for control of hand movements after cortical stroke69. This
threshold echoes similar findings by Stinear et al70, who found that meaningful gains from a
motor intervention were not possible with CST FA asymmetry >0.25. Identification of such
threshold values may be useful for stratifying individuals to an intervention in a clinical trial
setting71.
Among the measures of neural function, iM1-cM1 functional connectivity best predicted
therapy-induced gains, a result also confirmed by the Lasso regression method. The current
finding that greater baseline iM1-cM1 functional connectivity predicted larger treatment
gains agrees with one26 but not a second25 prior study, perhaps due to differences in the
population studied or the connectivity technique used. Overall this finding is concordant
with cross-sectional studies that have found greater inter-hemispheric connectivity to be
correlated with smaller motor deficits after stroke in humans72, 73 and an animal stroke
model74. The exact manner by which iM1-cM1 functional connectivity is related to
treatment gains in the current cohort is uncertain and could reflect changes in motor cortex
activity53, 75, 76, contralesional hemisphere excitability77, ipsilesional hemisphere
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excitability78-80, or inter-hemispheric inhibition81-83. The results underscore the potential
value of connectivity measures for understanding behavioral state after stroke84, and support
prior reports85-87 that connectivity may have advantages over regional assessments of brain
function for some questions.
Prediction of treatment-induced behavioral gains -- stroke subtype

NIH-PA Author Manuscript

Results supported the secondary hypothesis that the best measures for predicting treatmentinduced behavioral gains vary according to stroke subtype (lacunar vs. non-lacunar).
Patients with a lacunar stroke tend to differ in multiple ways from patients with a nonlacunar stroke, including risk factor profile39, 88, lesion volume54, and clinical
prognosis89, 90 39-45. The current results extend this list, suggesting that patients with lacunar
stroke might also differ in terms of measures predicting response to a restorative therapy.
The strongest predictors of treatment-induced behavioral gains among patients in the lacunar
subgroup were measures of cortical function and intra-hemispheric cortical connectivity,
specifically greater M1 activation and greater iM1-iPMd functional connectivity. This
contrasts with findings among patients in the non-lacunar subgroup, where measures of
brain injury and inter-hemispheric cortical connectivity best predicted treatment gains. The
importance of cortical function to treatment gains after lacunar infarct is consistent with
prior results91, 92. The basis for the observed difference between stroke subtypes is uncertain
but may be related to cortical excitability, as affected arm movements increase motor cortex
excitability after subcortical but not cortical stroke 93, or to lesion-specific differences in
patterns of post-stroke brain plasticity91, 93.
Study considerations and limitations

NIH-PA Author Manuscript

Strengths of the current study include examination of multiple classes of candidate predictor
variables in parallel, attention to stroke subtype, and confirmation of results using
independent statistical methods. The heterogeneity of the current cohort is both a strength
and a limitation. There is a balance between studying a narrowly defined population of
stroke survivors, where statistical power is high due to low variance but results do not
generalize, versus a broadly defined population, among whom heterogeneity limits statistical
power but results are more likely to generalize. Enrollment in the current study (Table 1)
prioritized time post-stroke (had to be early after the time when spontaneous arm motor
recovery reaches a plateau after stroke46, 47) and severity of stroke (a wide range of motor
deficits was allowed albeit minor nor devastating). Studies that enroll in relation to different
priorities or that focus on different therapies might reach different findings regarding
predictors of treatment gains.
Weaknesses of the study include the possibility that results of genetic analyses may suffer
from Type II error. Although studies with comparable sample sizes have found significant
predictive value for these genotypes with respect to motor learning94-97, the current study
may have been insufficiently powered to detect an association between genotype and
treatment-induced behavioral gains in the setting of stroke. The multivariate predictive
model explained only 44% of the variance in treatment-induced behavioral gains; the
predictive value of this model in other study populations would likely vary depending on the
degree of homogeneity of such cohorts. What might account for the remaining variance? A
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number of candidate measures might be considered, across a range of biopsychosocial
factors important to stroke outcomes, including socioeconomic factors98, stress level99,
other genes100, caregiver status101, neurophysiological status37, and other cognitive/
psychological tests102.
The current findings indicate that across all patients a multivariate approach combining
measures of neural injury and neural function best predicts behavioral gains from a
standardized course of therapy in patients who have recently reached a plateau in
spontaneous recovery. The approach to predicting treatment-induced behavioral gains varies
in relation to stroke subtype. The findings also emphasize that neuroimaging methods may
have a role in clinical decision-making for rehabilitation therapy after stroke is currently
driven by clinical assessments65.
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Figure 1.

Across all subjects, (A) Smaller percent injury to M1 corticospinal tract (r=-0.49, p=0.007)
and (B) greater ipsilesional M1-contralesional M1 functional connectivity (r=0.45, p=0.01)
each significantly predicted larger treatment-induced behavioral gains. Behavioral gains
were assessed as the principal component of the change in FM and ARAT scores from
baseline to one-month post-therapy. To aid interpretation, the change in FM score is
included on the Y-axis.
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Figure 2.

Regression coefficients determined using the group Lasso regression method. Variables
identified as important for treatment-induced behavioral gains came from the cortical
connectivity, cortical function, and brain injury categories.
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Figure 3.

In the subgroup of patients with a lacunar infarct, greater (A) ipsilesional M1 activation
(r=0.79, p=0.02) and (B) ipsilesional M1-ipsilesional PMd functional connectivity (r=0.81,
p=0.02) each significantly predicted larger treatment-induced behavioral gains. Behavioral
gains were assessed as the principal component of the change in FM and ARAT scores from
baseline to one-month post-therapy. To aid interpretation, the change in FM score is
included on the Y-axis.

Ann Neurol. Author manuscript; available in PMC 2016 January 01.

Quinlan et al.

Page 21

Table 1

NIH-PA Author Manuscript

Inclusion and exclusion criteria.
Inclusion criteria

Exclusion criteria

Age ≥ 18 years

Contraindication to MRI

Stroke with onset 11-26 weeks prior

Severe cognitive impairment

Residual arm motor deficit (ARAT<52 or 9-hole peg test score > 25% longer than with
unaffected hand

Concurrent diagnosis affecting arm/hand function
Arm motor status not at stable plateau

Preserved voluntary movements in distal upper extremity (≥5 degrees of active range of
motion in affected wrist or index finger metacarpophalangeal joint

NIH-PA Author Manuscript
NIH-PA Author Manuscript
Ann Neurol. Author manuscript; available in PMC 2016 January 01.

Quinlan et al.

Page 22

Table 2

NIH-PA Author Manuscript

Baseline measures.
All patients

Non-lacunar

Lacunar

29

21

8

56.5 (13.9)

55.3 (13.9)

55.3 (5.4)

4.3 (1.0)

4.2 (1.0)

4.5 (0.9)

Gender

8 F/ 21 M

7 F/ 14 M

1 F/ 7 M

Diabetes mellitus

8 Y/ 21 N

6 Y/ 15 N

2 Y/ 6 N

Hypertension

14 Y/ 15 N

8 Y/ 13 N

6 Y/ 2 N

Hypercholesterolemia

12 Y/ 17 N

6 Y/ 15 N

6 Y/ 2 N

Mini Mental State Exam (normal = 30)

27.5 [25-30]

28 [25-30]

27 [25.25-29.75]

Geriatric Depression Scale (normal = 0)

3.0 [1.5-4.5]

2 [0.5-4]

3 [2-6.75]

Number
Demographics/medical history
Age (years)
Time post-stroke (months)

Cognitive/mood

Impairment
NIH Stroke Scale (normal = 0)

NIH-PA Author Manuscript

4.2 (1.8)

4.4 (1.7)

3.5 (1.9)

Fugl-Meyer Scale (normal = 66)

36.3 (14.8)

35.7 (16.1)

37.7 (11.7)

Action Research Arm Test (normal = 57)

26.2 (18.8)

25.7 (20.2)

27.5 (15.9)

13.5 (4.3)

12.2 (4.4)

16.9 (0.4)

BDNF val66met polymorphism present

8 Y/ 21 N

5 Y/ 16 N

3 Y/ 5 N

ApoE4 allele present

4 Y/ 25 N

2 Y/ 19N

2 Y/ 6 N

Infarct volume (cc)

32.6 (48.4)

44.6 (52.3)

1.2 (0.6)

Precentral gyrus injury?

14 Y/ 15 N

14 Y/ 7 N

0 Y/ 8 N

Nottingham Sensory Assessment (normal = 17)
Genetics

Brain injury

Precentral gyrus injury (cc)

0.61 (1.1)

0.85 (1.2)

0

Cortical PMd injury?

10 Y/ 19 N

10 Y/ 11 N

0 Y/ 8 N

Cortical PMd injury (cc)

0.25 (0.52)

0.34 (0.58)

0

21 Y/ 8 N

21 Y/ 0 N

0 Y/ 8 N

Total cortical injury (cc)

19.8 (33.6)

27.3 (69.9)

0

Corticospinal tract integrity (DTI FA)

0.39 (0.12)

0.39 (0.13)

0.36 (0.08)

Percent injury to CST

54.5 (32.6)

61.2 (34.2)

35.2 (18.0)

Ipsilesional M1 activation - contrast estimate

2.9 (1.9)

2.6 (1.9)

3.7 (1.7)

Ipsilesional PMd activation - contrast estimate

2.0 (1.3)

1.8 (1.5)

2.3 (1.0)

Contralesional M1 activation - contrast estimate

1.7 (1.3)

1.6 (1.3)

1.9 (1.2)

Contralesional PMd activation - contrast estimate

2.2 (1.7)

2.2 (1.7)

2.3 (1.7)

Ipsilesional M1 activation volume (voxels)

67 (42)

64 (44)

72 (38)

Ipsilesional PMd activation volume (voxels)

43 (46)

40 (46)

49 (47)

Contralesional M1 activation volume (voxels)

39 (41)

38 (42)

42 (42)

Contralesional PMd activation volume (voxels)

49 (42)

45 (44)

45 (41)

Cortical injury?
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Cortical function

Cortical connectivity
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All patients

Non-lacunar

Lacunar

iM1-iPMd correlation coefficient

0.31 (0.32)

0.28 (0.30)

0.38 (0.38)

iM1-cM1 correlation coefficient

0.13 (0.30)

0.14 (0.30)

0.13 (0.31)

iM1-cPMd correlation coefficient

0.10 (0.21)

0.11 (0.19)

0.07 (0.26)
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Bivariate correlations between baseline measures and arm motor gains with therapy--all patients.
Baseline variable

Correlation with treatment-induced motor gains
r

p

Age

0.07

0.72

Time post-stroke

0.06

0.76

Gender (M/F)

0.03

0.80

Diabetes mellitus (y/n)

-0.04

0.71

Hypertension (y/n)

0.04

0.86

Hypercholesterolemia (y/n)

0.09

0.60

Mini Mental State Exam

-0.13

0.50

Geriatric Depression Scale

0.11

0.58

NIH Stroke Scale

-0.26

0.17

Mean baseline Fugl-Meyer

-0.05

0.79

Mean baseline Action Research Arm Test

0.04

0.82

Nottingham Sensory Assessment

0.25

0.20

BDNF val66met polymorphism present (y/n)

0.19

0.35

ApoE4 allele present (y/n)

0.19

0.43

Infarct volume (cc)

-0.42

0.02*

Precentral gyrus injury (y/n)

-0.15

0.54

Precentral gyrus injury (cc)

-0.18

0.36

Cortical PMd injury (y/n)

-0.28

0.07

Cortical PMd injury (cc)

-0.36

0.06

Cortical injury (y/n)

-0.46

0.008*

Total cortical injury (cc)

-0.41

0.03*

Corticospinal tract integrity (DTI FA)

0.18

0.34

Percent injury to CST

-0.49

0.007**

Ipsilesional M1 activation - contrast estimate

0.37

0.045*

Ipsilesional PMd activation - contrast estimate

0.36

0.05

Contralesional M1 activation - contrast estimate

0.28

0.14

Contralesional PMd activation - contrast estimate

-0.01

0.95

Ipsilesional M1 activation volume

0.16

0.40

Ipsilesional PMd activation volume

0.02

0.92

Demographics/medical history

Cognitive/mood

Impairment
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Brain injury
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Cortical function
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Correlation with treatment-induced motor gains
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r

p

Contralesional M1 activation volume

-0.01

0.94

Contralesional PMd activation volume

-0.10

0.60

Ipsilesional M1-Ipsilesional PMd connectivity

0.11

0.58

Ipsilesional M1-Contralesional M1 connectivity

0.45

0.01*

Ipsilesional M1-Contralesional PMd connectivity

0.13

0.50

Cortical connectivity

*

For normally distributed variables, r is the Pearson correlation coefficient. For variables that are not normally distributed, r is Spearman's rho. For

dichotomous variables, X2 is presented. The change in motor behavior was assessed as the principal component of change in FM and ARAT scores
from baseline to one-month post-therapy.
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Multivariate predictor model--all patients.
Variable

Estimate

Standard Error

95% CI

P

Intercept

0.269

0.890

--

0.765

Ipsilesional M1 activation - contrast estimate

0.276

0.161

-0.05 to 0.61

0.10

iM1-cM1 connectivity

2.57

1.005

0.49 to 4.64

0.017*

Percent injury to CST

-0.020

0.010

-0.40 to -0.0001

0.049*
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